Dr. Devyani Mehta Hunt, MD

Dr. Hunt practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Hunt's NPI, 1053339770, was assigned on July 18, 2006. Dr. Hunt graduated from University of Texas Medical School at Houston in 2000. Dr. Hunt holds Missouri license 2004002419.

Dr. Hunt's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Hunt also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Hunt's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Hunt is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Hunt to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hunt practices, 7 sites in all. Vendor and product names are available with a free account.

Physical medicine and rehabilitation is Dr. Hunt's primary specialty in the NPI Registry, under taxonomy code 208100000X. Dr. Hunt is board certified in sports medicine by the American Board of Emergency Medicine. Dr. Hunt is licensed in Missouri.

CMS data shows 1,231 Medicare services from Dr. Hunt across 11 procedure codes in 2024, for 320 Medicare patients. Medicare paid $60,147 for them.

CMS counts 320 Medicare patients who saw Dr. Hunt in 2024. The largest group is 65 to 74, with 149 patients. 75% of them have arthritis, and 73% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hunt's median patient age at 70, with 73% women.

In 2024, Dr. Hunt wrote 1,202 Medicare Part D claims for 208 patients. 99% of them were for generic drugs. CMS names the drug for 1,137 of them, across 15 drugs with 11 or more claims each, at $20,949 in total drug cost. In 2023, CMS named 1,112 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Hunt for performance year 2024, reported as part of a group. Dr. Hunt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hunt as offering telehealth.

Dmand AI links 34 papers to Dr. Hunt, published from 2012 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Hip Joint, Acetabulum and Hip Dislocation. Dr. Hunt has published most often in PM R. Dr. Hunt's most frequent co-authors are Abby Ling-Lee Cheng, MD, Monica E. Rho, MD and Scott Albert Simpson, MD.

CMS Open Payments shows 1 general payment to Dr. Hunt from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. MML US, Inc. paid the most, $123.

Dr. Hunt graduated from University of Texas Medical School at Houston in 2000.